Answers are grounded in this paper and cite their sources.
BACKGROUNDMany transcriptome-based signatures for hepatocellular carcinoma (HCC) prognosis have been reported, but most show limited portability across cohorts.We hypothesized that a network-guided analysis of harmonized liver transcriptomes could identify a biologically coherent and portable prognostic signature. AIMTo identify biologically coherent co-expression modules and develop a robust expression signature for HCC prognosis. METHODSWe used uniformly processed RNA-seq data from the University of California Santa Cruz Toil recompute compendium to integrate The Cancer Genome Atlas (TCGA)-liver HCC tumors (n = 371), TCGA adjacent non-tumor liver (n = 50), and Genotype-Tissue Expression normal liver (n = 110).After filtering out low-expression genes and selecting 8000 most variable ones according to their median absolute deviation, we performed weighted gene co-expression network analysis to identify co-expression modules in tumor and normal tissues, which was followed by hub-gene prioritization, enrichment analysis, least absolute shrinkage and selection operator-Cox modeling, external validation, and meta-analysis. RESULTSWeighted gene co-expression network analysis identified a tumor-associated module enriched for cell-cycle progression, mitotic checkpoint control, DNA replication, E2F targets, and mTORC1 signaling.A normal-liver-associated module showed a distinct expression module enriched for detoxification, metal-ion/toxin response, and liver 5 / 51 homeostatic functions.Cross-platform filtering, survival-analysis screening and least absolute shrinkage and selection operator-Cox modeling yielded a 3-gene signature consisting of MMP1, KIF2C, and HOXD10.In TCGA, the signature-based risk score was significantly associated with overall survival, and the association remained significant after adjustment for age at diagnosis, sex, and disease stage (hazard ratio = 2.95, 95% confidence interval: 1.92-4.53,P = 8.10 × 10 -7 ).The TCGA-derived coefficients were then applied to six external cohorts, with adverse prognostic associations observed in the same direction across all cohorts, although statistical significance varied among individual datasets.Random-effects meta-analysis yielded a pooled hazard ratio of 1.54 (95% confidence interval: 1.30-1.82)per 1-SD increase in risk score (I 2 = 39.8%). CONCLUSIONThe network-guided analysis of a harmonized TCGA-Genotype-Tissue Expression liver transcriptome identified a biologically coherent survival-related expression signature with cross-platform prognostic associations in retrospective cohorts.This signature represents a candidate prognostic model requiring prospective assay-based validation and evaluation of clinical utility.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: